About Lou
Gehrigs Disease
Lou
Gehrigs Disease is a rapidly progressive, invariably fatal
neurological disease that attacks the nerve cells (neurons)
responsible for controlling voluntary
muscles.
In Lou
Gehrigs Disease, both the upper motor neurons and the lower
motor neurons degenerate or die, ceasing to send messages to
muscles.Unable to function, the muscles gradually weaken, waste
away, and twitch.
Eventually
the ability of the brain to start and control voluntary
movement is lost. Individuals with Lou Gehrigs Disease lose
their strength and the ability to move their arms, legs, and
body.
When
muscles in the diaphragm and chest wall fail, individuals lose
the ability to breathe without ventilatory
support.
In most
cases the disease does not impair a person's mind, personality,
intelligence, or memory, nor does it affect a person's ability
to see, smell, taste, hear, or recognize
touch.
A small
percentage of patients may experience problems with memory or
decision-making, and there is growing evidence that some may
even develop a form of dementia. The cause of Lou
Gehrigs Disease is not known, and scientists do not yet know
why Lou Gehrigs Disease strikes some people and not
others.
Treatment
No cure
has yet been found for Lou Gehrigs Disease. However, the FDA
has approved the first drug treatment for the disease—riluzole.
Riluzole is believed to reduce damage to motor neurons and
prolongs survival by several months, mainly in those with
difficulty swallowing.
Other
treatments are designed to relieve symptoms and improve the
quality of life for people with Lou Gehrigs
Disease.
Drugs also
are available to help individuals with pain, depression, sleep
disturbances, and constipation. Individuals with Lou Gehrigs
Disease may eventually consider forms of mechanical ventilation
(respirators).
Prognosis
Regardless
of the part of the body first affected by the disease, muscle
weakness and atrophy spread to other parts of the body as the
disease progresses.
Individuals have increasing problems with moving,
swallowing, and speaking or forming words. Eventually people
with Lou Gehrigs Disease will not be able to stand or walk, get
in or out of bed on their own, or use their hands and
arms.
In later
stages of the disease, individuals have difficulty breathing as
the muscles of the respiratory system weaken. Although
ventilation support can ease problems with breathing and
prolong survival, it does not affect the progression of Lou
Gehrigs Disease.
Most
people with Lou Gehrigs Disease die from respiratory failure,
usually within 3 to 5 years from the onset of symptoms.
However, about 10 percent of those individuals with Lou Gehrigs
Disease survive for 10 or more years.
Research
Public
Health Authorities conduct research in laboratories and support
additional research through grants to major medical
institutions across the country.
The goals
of this research are to find the cause or causes of Lou Gehrigs
Disease, understand the mechanisms involved in the progression
of the disease, and develop effective
treatments.
Reference for Lou
Gehrigs Disease Article
National Institutes
of Health
Health
Related Websites
The National Cancer
Institute
The National Eye
Institute
The National Heart, Lung,
and Blood Institute
National Institute on
Aging
National Institute of
Allergy and Infectious Diseases
National Institute of
Arthritis and Musculoskeletal and Skin Diseases
National Institute of
Diabetes and Digestive and Kidney Diseases
National Institute on Drug
Abuse
National Institute of Mental
Health
National Institute of
Neurological Disorders and Stroke
|